Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT India 100BT GolfBT Mindrush
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Bharat Parenterals Ltd
Bharat Parenterals Ltd

Bharat Parenterals Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 1,477
Aug 08, 2025 Closed
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹1,387.25
₹-60.45 (-4.18%)
1,380.00Low
Today’s Performance
1,467.50High
802.00Low
52 Week’s Performance
1,870.00High

bt_logoStock Performance

  • 1 Day-4.18%
  • 1 Week-8.74%
  • 1 Month0.41%
  • 3 Months24.81%
  • 6 Months8.70%
  • 1 Year-24.23%
  • 3 Years58.01%
  • 5 Years26.09%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.44
  • 52-Week Low (₹)802.00
  • 52-Week High (₹)1,870.00
  • Price-to-Book (X)*2.89
  • Dividend Yield (%)0.07
  • Price-to-Earnings (P/E) (X)*-168.56
  • Earnings Per Share (₹)-8.23
  • Market Cap (₹ Cr.)*956.09
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Haseeb Drabu Vs N K Singh: Bureaucracy, Federalism & Power Play | BT India@1002:28Haseeb Drabu Vs N K Singh: Bureaucracy, Federalism & Power Play | BT India@100
Gadkari: E20 Cuts Mileage Slightly but Doesn’t Damage Vehicles, Petroleum Lobby Fuelling Fear5:23Gadkari: E20 Cuts Mileage Slightly but Doesn’t Damage Vehicles, Petroleum Lobby Fuelling Fear
Leadership Drives State Growth: Arvind Panagariya On India's Top States By 20473:36Leadership Drives State Growth: Arvind Panagariya On India's Top States By 2047
Centre Vs States: N K Singh & Haseeb Drabu Debate Fiscal Federalism | BT India@1006:35Centre Vs States: N K Singh & Haseeb Drabu Debate Fiscal Federalism | BT India@100
India’s Diplomatic Game Plan Against U.S. Trade Pressures | Neelkanth Mishra3:28India’s Diplomatic Game Plan Against U.S. Trade Pressures | Neelkanth Mishra
Gen Beta’s New Money Mindset | Rachana Ranade, AssetYogi & More At BT India@10035:53Gen Beta’s New Money Mindset | Rachana Ranade, AssetYogi & More At BT India@100
The Sunrise Sectors That Will Drive India’s Growth | Rajat Dhawan At India@10020:52The Sunrise Sectors That Will Drive India’s Growth | Rajat Dhawan At India@100
US Tariff Hypocrisy? Amul & GTRI Hit Back On Dairy, Agri Access | BT India@1002:00US Tariff Hypocrisy? Amul & GTRI Hit Back On Dairy, Agri Access | BT India@100
McKinsey’s Rajat Dhawan on How India’s Innovation Will Drive $30T Economy1:26McKinsey’s Rajat Dhawan on How India’s Innovation Will Drive $30T Economy
Shaping A Healthy Future For Bharat | Shobana Kamineni, Ashutosh Raghuvanshi At BT India@10021:07Shaping A Healthy Future For Bharat | Shobana Kamineni, Ashutosh Raghuvanshi At BT India@100
View more

bt_logoFAQ's

What was Bharat Parenterals Ltd share price previously?
Bharat Parenterals Ltd share price was down by -4.18% from the previous closing price of ₹1,447.70.
Who are peers of Bharat Parenterals Ltd?
The peers of Bharat Parenterals Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Bharat Parenterals Ltd?
The promotor/promotors of Bharat Parenterals Ltd are Bharat Kumar R Desai, Hemang Jayendrabhai Shah, Shaileshkumar Ghabhawala, Zankhana Sheth, Mukesh Patel, Alkesh Jayantilal Shah.
What has been 52-week high of Bharat Parenterals Ltd stocks?
The highest price of Bharat Parenterals Ltd stock is ₹1,870.00 in the last 52-week.
What is the share price of Bharat Parenterals Ltd (BPLPHARMA) today on BSE?
As on Aug 08, 2025 Bharat Parenterals Ltd (BPLPHARMA)’s share price on BSE is Rs 1387.25
What is the market cap of Bharat Parenterals Ltd (BPLPHARMA)?
The current market capitalisation of Bharat Parenterals Ltd (BPLPHARMA) is 956.09 crores
What is Bharat Parenterals Ltd Share symbol?
The symbol of Bharat Parenterals Ltd is .
What is the PE ratio of Bharat Parenterals Ltd (BPLPHARMA)?
The current PE ratio of Bharat Parenterals Ltd (BPLPHARMA) is -168.56.
What is the PB ratio of Bharat Parenterals Ltd (BPLPHARMA)?
The current PB ratio of Bharat Parenterals Ltd (BPLPHARMA) is 2.89.
Today’s High & Low share prices of Bharat Parenterals Ltd (BPLPHARMA) on BSE?
Today, the share price of Bharat Parenterals Ltd (BPLPHARMA) on BSE touched a high of Rs 1467.5 and a low of Rs 1380
What price did Bharat Parenterals Ltd (BPLPHARMA) shares open on the BSE today?
On BSE, the share price of Bharat Parenterals Ltd (BPLPHARMA) opened at Rs 1454.9
What is the 52-week high of Bharat Parenterals Ltd (BPLPHARMA)?
The 52-week high price of Bharat Parenterals Ltd (BPLPHARMA) is Rs 1,870.00
What is the 52-week low of Bharat Parenterals Ltd (BPLPHARMA)?
The 52-week low price of Bharat Parenterals Ltd (BPLPHARMA) is Rs 802.00

bt_logoAbout Bharat Parenter.

Bharat Parenterals Ltd, incorporated in the year 1992, has its registered office in Survey No 144 & 146 Haripura, Jarod Samlaya Road Tal Savli, Vadodara, Gujarat, 391520, 91-2667-251679, 91-2667-251670. The main industry in which Bharat Parenterals Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Bharat Parenterals Ltd is/are CNK & Associates LLP/Shah Mehta & Bakshi. In the main management, is chairman and is the company secretary for Bharat Parenterals Ltd.

  • BKRD
    Bharat Kumar R DesaiManaging Director
  • HJS
    Hemang Jayendrabhai ShahExecutive Director
  • SG
    Shaileshkumar GhabhawalaNon Executive Director
  • ZS
    Zankhana ShethIndependent Director
  • MP
    Mukesh PatelIndependent Director
  • AJS
    Alkesh Jayantilal ShahNon Executive Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.